Johns Hopkins HIV Guide
Paromomycin
INDICATIONS
FDA
FDA
- Intestinal amebiasis
- Hepatic coma
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Cryptosporidiosis
- Dientamoeba fragilis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 4, 2016
Citation
Smith, Janessa, and Paul A Pham. "Paromomycin." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545159/all/Paromomycin.
Smith J, Pham PA. Paromomycin. Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545159/all/Paromomycin. Accessed June 1, 2023.
Smith, J., & Pham, P. A. (2016). Paromomycin. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545159/all/Paromomycin
Smith J, Pham PA. Paromomycin [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2023 June 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545159/all/Paromomycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Paromomycin
ID - 545159
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2016/10/04/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545159/all/Paromomycin
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
